FDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the US

Argentina Noticias Noticias

FDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the US
Argentina Últimas Noticias,Argentina Titulares
  • 📰 AP
  • ⏱ Reading Time:
  • 53 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 51%

U.S. regulators have sent warning letters to dozens of retailers selling fruity disposable e-cigarettes, including the current best-selling brand, Elf Bar.

FILE - The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015. The FDA on Thursday, June 22, 2023, said it has sent warning letters to dozens of retailers selling fruit- and candy-flavored disposable e-cigarettes, including the current best-selling brand, Elf Bar. It’s the latest attempt by regulators to crack down on illegal disposable vapes that have poured into U.S. stores in recent years.

It’s the latest attempt by regulators to crack down on illegal disposable vapes that have poured into U.S. stores in recent years.Esco Bar “We’re not going to stand by as bad actors are profiting off the sale of illegal products that are addicting our nation’s youth,” Brian King, the FDA’s tobacco center director, said in an interview. “Today’s action is just part of our long-standing efforts to address those products, particularly flavored disposable products.”, but separate data released by government researchers Thursday shows unauthorized e-cigarettes continue to launch.

Researchers from the CDC and a nonprofit, Truth Initiative, analyzed data from IRI, which collects sales records from convenience stores, gas stations and other retailers. When accidentally ingested, liquid nicotine can cause seizures, convulsions, vomiting and brain injury. Reports of nicotine poisoning have gone up and down over the past decade, but government scientists said calls increased more than 30% between last spring and March this year.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

AP /  🏆 728. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the USFDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the USU.S. regulators have sent warning letters to dozens of retailers selling fruity disposable e-cigarettes, including the current best-selling brand, Elf Bar
Leer más »

New Austin bar 'Sign Bar' now open featuring 75+ signs from legendary local businessesNew Austin bar 'Sign Bar' now open featuring 75+ signs from legendary local businessesFeeling a little nostalgic? A new Austin bar displaying over 75 classic signs from legendary local businesses across the city is now open.
Leer más »

“Secret Garden bar in Dupont Circle” - PoPville“Secret Garden bar in Dupont Circle” - PoPvillecourtesy Hank’s Oyster Bar From an email: 'a new outdoor alley bar at woman-owned Hank’s Oyster Bar. Q Street Secret Garden Bar: Hank’s Oyster Bar’s new secret garden bar, Q Street, at the Dupont Circle location. Head down the alley between Fox & Hound and Agora and emerge into this secret garden oasis that’s open
Leer más »

FDA Warns of Tattoo Ink Tied to Dangerous InfectionsFDA Warns of Tattoo Ink Tied to Dangerous InfectionsThe FDA released the new draft guidance aiming to reduce the use of pathogen-contaminated tattoo ink, which can cause stubborn infections that are especially hard to treat, dermatologists said.
Leer más »

FDA OKs Empagliflozin for Children With Type 2 DiabetesFDA OKs Empagliflozin for Children With Type 2 DiabetesThe FDA has approved empagliflozin and empagliflozin combined with metformin for the treatment of type 2 diabetes in children aged 10 years and older.
Leer más »

FDA Approves Talazoparib for Metastatic Prostate CancerFDA Approves Talazoparib for Metastatic Prostate CancerThe oral PARP inhibitor talazoparib in combination with enzalutamide provides a new treatment option for patients with HRR gene–mutated metastatic castration-resistant prostate cancer.
Leer más »



Render Time: 2025-04-08 05:28:21